Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): An Overview and Lessons Learned-Reference-Cited by-同舟云学术

Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): An Overview and Lessons Learned

Published:2018-10-10 Issue:suppl_4 Volume:218 Page:S188-S194
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Barkume Caitlin¹,Date Kashmira²,Saha Samir K³,Qamar Farah Naz⁴,Sur Dipika⁵,Andrews Jason R⁶,Luby Stephen P⁶,Khan M Imran¹,Freeman Alex¹,Yousafzai Mohammad Tahir⁴,Garrett Denise¹

Affiliation:

1. Typhoid Programs, Sabin Vaccine Institute, Washington, D. C

2. Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia

3. Child Health Research Foundation, Department of Microbiology, Dhaka Shishu (Children) Hospital, Bangladesh

4. Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan

5. Translational Health Science and Technology Institute, Faridabad, India

6. Infectious Diseases and Geographic Medicine, Stanford University, California

Funder

Bill and Melinda Gates Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/218/suppl_4/S188/27230263/jiy522.pdf

Reference26 articles.

1. Global, regional and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016;GBD 2016 Disease and Injury Incidence and Prevalence Collaborators;Lancet,2017

2. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016;GBD 2016 Causes of Death Collaborators;Lancet,2017

3. Typhoid vaccines: WHO position paper—March 2018;World Health Organization;Wkly Epidemiol Rec,2018

4. Seroefficacy of Vi polysaccharide-tetanus toxoid typhoid conjugate vaccine (Typbar TCV);Voysey;Clin Infect Dis,2018

5. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial;Jin;Lancet,2017

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Results of Work of Infectious Disease Specialists and Epidemiologists of the Rospotrebnadzor during the Outbreak of Acute Intestinal Infections in the Republic of the Congo (Brazzaville) in 2023;Problems of Particularly Dangerous Infections;2024-04-04

2. Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study;The Lancet Global Health;2024-03

3. Scope of antibiotic stewardship in enteric fever: An evidence-based summary;Tropical Doctor;2024-02-29

4. Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers;Human Vaccines & Immunotherapeutics;2024-01-08

5. A Novel Algorithm for Predicting Antimicrobial Resistance in Unequal Groups of Bacterial Isolates;International Journal of Statistics in Medical Research;2023-11-24